Metabolic Health & Weight Optimization

Tesamorelin is the one growth-hormone peptide with real clinical evidence for reducing deep belly fat. A clear, evidence-based look at how it works, the approved use, off-label interest, side effects, and safety.

A weight-loss plateau on semaglutide or tirzepatide is normal and expected. Here is why it happens (metabolic adaptation, dose, muscle loss, dietary drift) and the practical, evidence-based ways to respond.

Branded semaglutide lists around $1,000 to $1,350 a month, but most people pay far less. A clear breakdown of list prices, self-pay programs, savings cards, insurance, telehealth, and the compounding situation in 2026.

Sermorelin and ipamorelin both raise growth hormone but through different pathways, which is why they are often combined rather than compared. A clear, evidence-based look at how each works, dosing, and safety.

Sermorelin is a GHRH analog that prompts your own pituitary to make more growth hormone. An honest, evidence-based look at how it works, the benefits, the limits of the evidence, side effects, and safety.

Some of the weight lost on semaglutide or tirzepatide is muscle, not fat. Here is what the research shows and the evidence-based ways to protect lean mass: protein, resistance training, and more.

Most semaglutide side effects are gastrointestinal and temporary. A clear, evidence-based look at common and serious side effects, who should avoid it, when to seek help, and how to manage them.

Tirzepatide produces some of the largest weight-loss results of any medication. A clear, evidence-based guide to how it works, expected results, the dosing schedule, side effects, and what to expect month by month.

Tirzepatide produces more weight loss on average; semaglutide has a longer track record and easier access. A clear, evidence-based comparison of the two leading GLP-1 medications.